Very interesting times and thanks for your excellent...

Very interesting times and thanks for your excellent contributions mxdbg and BMD.
I have a query
The March ASX release indicated the company had identified 3 candidates for testing but no mention of 225.
When did 225 come into the mix and ultimately provided us with a shot at the big time.
Have I missed something?
As you have both correctly identified this could all happen very quickly.
A 5 day course with a drug that already has an established safety profile could be undertaken in Australia cheaply and expeditiously.
There would be no shortage of trial candidates I believe
A positive outcome would have Pharma scrambling to participate.
I’ve been here for a decade and never felt as positive about the company’s prospects.
The planets do appear to be aligning and the market has missed signals ……thus far!

GLTAH
FF